Regeneron Pharmaceuticals
  • REGN

  • $759.18

  • +0.55%
  • $755.02

  • $773.72

  • $742.74

Prices as of 2026-02-03 16:20:44 ET

Ticker Appearances

Daily Technical Strategy
Wed, January 7, 2026 | 9:51PM ET

Healthcare being raised to Overweight after breakout

NEAR-TERM EQUITY TRENDS ARE BULLISH, AND IT’S EXPECTED THAT QQQ WILL SOON BREAK OUT TO JOIN THE MOVE BACK TO NEW HIGHS, WHICH HAS BEEN...

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Thu, September 25, 2025 | 6:57PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Live Technical Stock Analysis
Tue, February 4, 2025 | 4:00PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Wed, September 25, 2024 | 6:52PM ET

Equal-weighted Industrials is showing very good relative strength

SHORT-TERM US EQUITY TRENDS ARE BULLISH AND LIKELY BEGIN TO ACCELERATE HIGHER INTO MID-OCTOBER BEFORE FINDING MUCH RESISTANCE.  DESPITE THE BEARISH SEASONALITY TRENDS, IT’S HARD...

Daily Technical Strategy
Thu, August 29, 2024 | 6:30PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Tue, May 28, 2024 | 8:12PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Live Technical Stock Analysis
Thu, April 4, 2024 | 4:00PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Wed, January 31, 2024 | 8:18PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Thu, January 11, 2024 | 7:34PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Daily Technical Strategy
Thu, January 4, 2024 | 6:50PM ET

Already have an account? Sign In

Visitor: 4f348d-8f1c88-65dc1f-b4df8d-5b2466

Events

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

Enjoyed the read? Subscribe now for unlimited access!

Get invaluable analysis of the market and stocks. Cancel at any time.

Already have an account? Sign In